Showing 1 - 10 of 68
The workshop addressed a variety of issues, including the magnitude of the pharmaceuticals market and the amounts of …
Persistent link: https://www.econbiz.de/10009640781
Persistent link: https://www.econbiz.de/10009641017
The negative external effects of profit orientated businesses on the environment and society are most visible and destructive in developing countries, where compensation measures for adversely affected groups rarely exist and where high corruption rates often impede meaningful enforcement of...
Persistent link: https://www.econbiz.de/10010254608
This paper provides a comparative assessment of the draft “Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems” as proposed by the European Commission in October 2004. The Regulation...
Persistent link: https://www.econbiz.de/10009638104
Persistent link: https://www.econbiz.de/10009640861
) exports. The sector supplies products to almost all downstream industry sectors and is an important engine for innovation for …
Persistent link: https://www.econbiz.de/10010254594
This background paper gives an overview of restructuring in Belgium from the first quarter of 2008 until the third quarter of 2010. Along with basic descriptive statistics outlining the employment effect of restructuring activities in Belgium, this overview includes brief narratives of...
Persistent link: https://www.econbiz.de/10011863883
Persistent link: https://www.econbiz.de/10009640917
European legislation regulating the marketing authorisation of medical products states that results from clinical trials that do not meet the ethical requirements of Good Clinical Practice, cannot legally be used by an applicant to justify its application, irrespective of whether the trial was...
Persistent link: https://www.econbiz.de/10010487943
Persistent link: https://www.econbiz.de/10009637057